The office-based opioid treatment (OBOT) model has transformed the behavioral health landscape in recent years. What began as a push to expand access to medication-assisted treatment (MAT) has evolved into a rapidly scaling segment of care—one defined not just by growth, but by the quality and sustainability of that growth.
According to Krysta, a member of the Council Capital team, the next phase of OBOT will be determined less by the number of patients served or clinics opened, and more by the strength and alignment of relationships between providers and payers. Her perspective underscores a critical point: expanding access alone is not sufficient to ensure long-term success.
From Access to Sustainable Growth
The expansion of OBOT has been both necessary and impactful. By moving treatment into accessible, community-based settings, providers have reduced barriers to care and improved outcomes for individuals with opioid use disorder.
Yet, as Krysta notes, “Scaling care without aligning incentives is like building a road without a bridge—it may lead somewhere, but it won’t connect where it needs to be.” Providers face rising operational complexity, workforce constraints, and reimbursement models that have not fully captured the long-term value OBOT creates.
This disconnect creates a fundamental tension: while providers deliver high-impact care that can reduce total healthcare costs, reimbursement structures often remain short-term and episodic.
Demonstrating Value Through Data
Krysta emphasizes that the key to bridging this gap is measurable, data-driven outcomes. Leading OBOT providers are increasingly integrating clinical care with behavioral health support and care coordination, creating models that are both clinically effective and economically compelling.
“The ability to show payers the impact of treatment—reduced hospitalizations, fewer emergency visits, and improved adherence—is what differentiates sustainable programs from short-lived pilots,” Krysta explains. By quantifying outcomes and communicating them effectively, providers can align their success with payer priorities.
Building Strong, Long-Term Partnerships
For OBOT to scale sustainably, relationships with payers must move beyond transactional interactions. As Krysta observes, “Long-term success requires partnership, not just contracts. Shared goals, trust, and transparency are essential.”
This includes:
- Aligning on shared clinical and financial outcomes
- Exploring alternative payment models, including value-based or bundled arrangements
- Engaging in ongoing collaboration to adapt to policy and patient needs
Krysta highlights that scale can be a significant advantage in these efforts—larger, integrated platforms often have the resources to invest in infrastructure, manage risk, and meaningfully engage with payers.
Policy Impacts and Public Payers
Public programs, particularly Medicaid, remain central to OBOT’s viability. Policy changes around coverage, eligibility, or reimbursement can directly affect patient engagement and provider economics. Krysta stresses that proactive payer engagement and diversified reimbursement strategies are essential to navigate this evolving landscape successfully.
Planning for Long-Term Success
The OBOT model has proven it can expand access and improve patient outcomes. The challenge now is building a system that is sustainable and scalable.
Krysta identifies the critical elements for long-term success:
- Alignment between clinical outcomes and reimbursement
- Data infrastructure to demonstrate value
- Strong, trust-based payer relationships
- Operational scale and efficiency
“The future of OBOT,” she concludes, “will not be defined solely by growth, but by the durability of the systems supporting care—and the strength of the partnerships behind them.”
By centering payer partnerships and measurable impact, providers and investors alike can help ensure OBOT’s promise endures.
